Periodic Reporting for period 1 - ThruBlood (Clinical validation of Trop-2 as a serum biomarker for monitoring of disease-course in patients affected by breast and colon cancer)

Cancer is the leading cause of death globally. Current follow-up approaches adopted for the screening of patients in the post-treatment phase of breast/colorectal cancer rely on technologies that are affected by strong limitations in terms of cost-effectiveness (i.e. imaging...